Skip to main content
. 2019 Oct 28;43(2):398–404. doi: 10.2337/dc18-2361

Figure 1.

Figure 1

Nonsevere hypoglycemic events (total and symptomatic) in the maintenance period of SWITCH 2 (A) and 1 (B) at different PG levels in a pooled randomized treatment data set. The event rates in the pooled randomized treatment data set (degludec and glargine U100) are plotted at a given PG level or lower. PYE, patient year of exposure.